Publication | Closed Access
Gypenoside LVI improves hepatic LDL uptake by decreasing PCSK9 and upregulating LDLR expression
26
Citations
12
References
2021
Year
Translational MedicineHepatologyMedicineLiver PhysiologyHepatic Ldl UptakePathologyHepatotoxicityLiver DiseaseFatty Liver DiseaseLiver TransplantationPharmacologyDrug-induced Liver InjuryGypenoside LviUpregulating Ldlr Expression
| Year | Citations | |
|---|---|---|
Page 1
Page 1